DJIA 17,020.84 -77.61 -0.45%
NASDAQ 4,577.81 -2.47 -0.05%
S&P 500 1,995.42 -7.95 -0.40%
market minute promo

Merck & Co., Inc. (NYSE: MRK)



company name or ticker
Company Photos
(Click to zoom)

Top-Yielding Stocks Dominate UBS Equity Focus List for September

Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri

Regeneron Pharmaceuticals and Sanofi's PCSK9 drug, alirocumab, reduces cardiovascular events, but the data come from a post-hoc analysis.

S.Korea lifts ban on beef with feed additive -food ministry

Market View For 2014 And 2015, The Investor's View

Bristol-Myers Squibb Gets European Approval For HCV Drug Daklinza

IYH, PFE, MRK, UNH: ETF Inflow Alert

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Dow Analyst Moves: MRK

I Am Sure This Pharma-Company Suits Your Portfolio

Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

See More Articles...